User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse




Journal Article

A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening


Leigh,  Kendra E.
Sofja Kovalevskaja Group, Max Planck Institute of Biophysics, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available

Gorgulla, C., Padmanabha Das, K. M., Leigh, K. E., Cespugli, M., Fischer, P. D., Wang, Z.-F., et al. (in press). A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience, 102021. doi:10.1016/j.isci.2020.102021.

Cite as: http://hdl.handle.net/21.11116/0000-0007-AAAF-5
The unparalleled global effort to combat the continuing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic over the last year has resulted in promising prophylactic measures. However, a need still exists for cheap, effective therapeutics and targeting multiple points in the viral life cycle could help tackle the current as well as future coronaviruses. Here we leverage our recently developed, ultra-large scale in silico screening platform, VirtualFlow, to search for inhibitors that target SARS-CoV-2. In this unprecedented structure-based virtual campaign, we screened roughly 1 billion molecules against each of 40 different target sites on 17 different potential viral and host targets. In addition to targeting the active sites of viral enzymes, we also targeted critical auxiliary sites such as functionally important protein-protein interactions.